| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010725434 |
| P356 | DOI | 10.1186/1745-6150-1-14 |
| P932 | PMC publication ID | 1523337 |
| P698 | PubMed publication ID | 16737543 |
| P5875 | ResearchGate publication ID | 7044457 |
| P2093 | author name string | Christopher Lee | |
| Lamei Chen | |||
| P2860 | cites work | Evidence for Positive Epistasis in HIV-1 | Q22242281 |
| HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs | Q24646227 | ||
| The adaptive evolution database (TAED) | Q24803703 | ||
| Vestige: maximum likelihood phylogenetic footprinting | Q24810693 | ||
| Correlated mutations and residue contacts in proteins | Q25891592 | ||
| Codon-substitution models for heterogeneous selection pressure at amino acid sites | Q27473194 | ||
| Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes | Q27631613 | ||
| Combining mutations in HIV-1 protease to understand mechanisms of resistance | Q27638993 | ||
| Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions | Q27860462 | ||
| Unbiased estimation of the rates of synonymous and nonsynonymous substitution | Q28266175 | ||
| Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy | Q28367526 | ||
| Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors | Q28379411 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Correlations among amino acid sites in bHLH protein domains: an information theoretic analysis | Q30011142 | ||
| Analysis of covariation in an SH3 domain sequence alignment: applications in tertiary contact prediction and the design of compensating hydrophobic core substitutions | Q30168699 | ||
| Coevolving protein residues: maximum likelihood identification and relationship to structure. | Q30321812 | ||
| Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy | Q31930788 | ||
| Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? | Q34364357 | ||
| Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies | Q34471322 | ||
| Linkage disequilibrium: what history has to tell us. | Q34511206 | ||
| HIV-1 subtype distribution and the problem of drug resistance | Q35868004 | ||
| Update of the drug resistance mutations in HIV-1: 2004. | Q35933981 | ||
| Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population | Q37002721 | ||
| Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. | Q39550343 | ||
| Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug | Q39612306 | ||
| Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments | Q39741937 | ||
| Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations | Q40317435 | ||
| Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase | Q40685006 | ||
| Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations | Q40688262 | ||
| Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana | Q40801868 | ||
| Structural comparison of major histocompatibility complex class I molecules and homology modelling of five distinct human leukocyte antigen-A alleles | Q40918449 | ||
| Correlated mutation analyses on very large sequence families | Q44166849 | ||
| A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance | Q44282271 | ||
| Multidrug Resistance to HIV-1 Protease Inhibition Requires Cooperative Coupling between Distal Mutations | Q44657961 | ||
| Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes | Q45090751 | ||
| Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333. | Q45740988 | ||
| Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. | Q46964850 | ||
| Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. | Q53970140 | ||
| Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples. | Q54044679 | ||
| Complete mutagenesis of the HIV-1 protease | Q59066144 | ||
| A method for detecting positive selection at single amino acid sites | Q73185955 | ||
| Evaluation of a novel method for the identification of coevolving protein residues | Q74575678 | ||
| Detection and reduction of evolutionary noise in correlated mutation analysis | Q81777329 | ||
| P921 | main subject | patient | Q181600 |
| drug resistance | Q12147416 | ||
| P304 | page(s) | 14 | |
| P577 | publication date | 2006-05-31 | |
| P1433 | published in | Biology Direct | Q1954915 |
| P1476 | title | Distinguishing HIV-1 drug resistance, accessory, and viral fitness mutations using conditional selection pressure analysis of treated versus untreated patient samples | |
| P478 | volume | 1 |
| Q34102058 | A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes |
| Q28483556 | Correlated electrostatic mutations provide a reservoir of stability in HIV protease |
| Q30358184 | Differential selection in HIV-1 gp120 between subtype B and East Asian variant B'. |
| Q28469203 | HIV-1 subtype B protease and reverse transcriptase amino acid covariation |
| Q28537991 | Identification of the critical sites of NNRTI-resistance in reverse transcriptase of HIV-1 CRF_BC strains |
| Q37298963 | Investigating protein-coding sequence evolution with probabilistic codon substitution models |
| Q21203781 | Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus |
| Q91754219 | Mapping the drivers of within-host pathogen evolution using massive data sets |
| Q41490002 | Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease |
| Q35120811 | Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis. |
| Q36259282 | Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution |
| Q33503921 | Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease |
| Q37550353 | Short Communication: Analysis of Selection Pressure and Mutational Pattern of HIV Type 1 Reverse Transcriptase Region Among Treated and Nontreated Patients |
| Q36433533 | Short Communication: Nucleotide Variation and Positively Selected Sites in HIV Type 1 Reverse Transcriptase Among Heterosexual Transmission Pairs |
| Q40103735 | The HIV positive selection mutation database |
| Q33668468 | Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans |
Search more.